General Information of Drug (ID: DMB6T7K)

Drug Name
Siramesine Drug Info
Synonyms
Siramesine; 147817-50-3; Lu-28-179; UNII-3IX8CWR24V; Lu 28-179; Siramesine(Lu 28-179); 3IX8CWR24V; CHEMBL61479; 1'-(4-(1-(4-fluorophenyl)-1H-indol-3-yl)butyl)-3H-spiro[isobenzofuran-1,4'-piperidine]; Siramesine [INN]; SCHEMBL2090079; QCR-66; C30H31FN2O; EX-A355; DTXSID90163810; XWAONOGAGZNUSF-UHFFFAOYSA-N; ZINC1533883; BCP08745; 4042AH; BDBM50035105; AKOS027251054; CS-1920; API0014138; NCGC00370727-06; HY-14221; 163630-80-6; 1'-(4-(1-(p-Fluorophenyl)indol-3-yl)butyl)spiro(phthalan-1,4'-piperidine)
Cross-matching ID
PubChem CID
9829526
ChEBI ID
CHEMBL61479
CAS Number
CAS 147817-50-3
TTD Drug ID
D0XK2K

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Steroid biosynthesis 2.49 0.00e+0 19/20 (95%) MSMO1;SQLE;SC5D;...
Glyoxylate and dicarboxylate metabolism 2.21 0.00e+0 23/30 (76.67%) ACAT2;DLD;GLUL;...
Valine, leucine and isoleucine degradation 1.95 7.99e-3 42/48 (87.5%) HMGCS1;ACAT2;ALDH2;...
Terpenoid backbone biosynthesis 1.94 8.99e-3 18/22 (81.82%) HMGCS1;ACAT2;IDI1;...
Propanoate metabolism 1.94 7.19e-3 30/34 (88.24%) ACAT2;ABAT;ACACA;...
Complement and coagulation cascades 1.93 7.99e-3 76/85 (89.41%) C1R;TFPI;PROS1;...
Glycine, serine and threonine metabolism 1.92 6.85e-3 31/40 (77.5%) GATM;DLD;PGAM1;...
Biosynthesis of unsaturated fatty acids 1.89 1.20e-2 21/27 (77.78%) SCD;FADS1;ELOVL6;...
Glutathione metabolism 1.86 1.60e-2 43/57 (75.44%) IDH1;GSTT1;PGD;...
Synthesis and degradation of ketone bodies 1.84 1.56e-2 9/10 (90%) HMGCS1;ACAT2;BDH1
Butanoate metabolism 1.83 1.42e-2 23/28 (82.14%) HMGCS1;ACAT2;ABAT;...
Rheumatoid arthritis 1.81 1.80e-2 78/93 (83.87%) CXCL1;ATP6V0E2;CXCL2;...
beta-Alanine metabolism 1.80 1.94e-2 25/30 (83.33%) ALDH2;DPYD;ABAT;...
Citrate cycle (TCA cycle) 1.75 3.00e-2 30/30 (100%) IDH1;IDH2;ACLY;...
Tryptophan metabolism 1.75 2.96e-2 35/42 (83.33%) ACAT2;ALDH2;AOX1;...
Amoebiasis 1.74 2.77e-2 99/102 (97.06%) PRKCA;CXCL1;GNAS;...
Morphine addiction 1.73 2.61e-2 80/91 (87.91%) PRKCA;GNAI1;GNAS;...
Fc gamma R-mediated phagocytosis 1.73 2.60e-2 79/97 (81.44%) MARCKSL1;PRKCA;PLPP3;...
Pyruvate metabolism 1.73 2.59e-2 41/47 (87.23%) ACAT2;ALDH2;ACACA;...
Ferroptosis 1.70 3.42e-2 36/41 (87.8%) ACSL3;TF;CP;...
Serotonergic synapse 1.70 3.42e-2 97/114 (85.09%) PRKCA;GNAI1;GNAS;...
Fatty acid biosynthesis 1.69 3.71e-2 16/18 (88.89%) ACSL3;FASN;ACACA;...
Amino sugar and nucleotide sugar metabolism 1.68 4.12e-2 38/48 (79.17%) GNE;GALE;GPI;...
Platelet activation 1.68 3.95e-2 106/124 (85.48%) GNAI1;GNAS;ACTB;...
African trypanosomiasis 1.66 4.46e-2 32/37 (86.49%) PRKCA;PLCB1;KNG1;...
Ribosome biogenesis in eukaryotes -1.97 3.44e-3 52/108 (48.15%) CSNK2B;GTPBP4;CSNK2A1;...
Ribosome -2.04 0.00e+0 113/158 (71.52%) RPS6;RPL37;RPS29;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Ewing sarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SK-ES-1 CVCL_0627 Homo sapiens 1.11uM - 10uM 24H
Brain
Glioma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
GI-1 CVCL_1230 Homo sapiens 1.11uM - 10uM 24H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.01uM - 10uM 24H
MDA-MB-468 CVCL_0419 Homo sapiens 1.11uM - 10uM 24H
Breast ductal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
T-47D CVCL_0553 Homo sapiens 1.11uM - 10uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.01uM - 10uM 24H
SNU-407 CVCL_5004 Homo sapiens 1.11uM - 10uM 24H
Endometrium
Endometrial adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEC-108 CVCL_2926 Homo sapiens 1.11uM - 10uM 24H
HEC-1-A CVCL_0293 Homo sapiens 1.11uM - 10uM 24H
HEC-251 CVCL_2928 Homo sapiens 1.11uM - 10uM 24H
HEC-265 CVCL_2929 Homo sapiens 1.11uM - 3.33uM 24H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CJM CVCL_U797 Homo sapiens 1.11uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 24H
Liver
Hepatocellular carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
JHH-5 CVCL_1320 Homo sapiens 1.11uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H1573 CVCL_1483 Homo sapiens 1.11uM - 10uM 24H
NCI-H838 CVCL_1594 Homo sapiens 1.11uM - 10uM 24H
Lung squamous cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BEN CVCL_1081 Homo sapiens 1.11uM - 10uM 24H
HCC95 CVCL_1276 Homo sapiens 1.11uM - 10uM 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H2110 CVCL_1529 Homo sapiens 1.11uM - 10uM 24H
Muscle
Rhabdomyosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-204 CVCL_0134 Homo sapiens 1.11uM - 10uM 24H
Ovary
Ovarian clear cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
OVTOKO CVCL_3114 Homo sapiens 1.11uM - 10uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
22Rv1 CVCL_1045 Homo sapiens 1.11uM - 10uM 24H
PC-3 CVCL_0035 Homo sapiens 0.01uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.01uM - 10uM 24H
IGR-37 CVCL_1303 Homo sapiens 1.11uM - 10uM 24H
Mel-HO CVCL_1402 Homo sapiens 1.11uM - 10uM 24H
SH-4 CVCL_1692 Homo sapiens 1.11uM - 10uM 24H
Urinary bladder
Bladder transitional cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CAL-29 CVCL_1109 Homo sapiens 1.11uM - 10uM 24H